State Street Cuts Stake in Rigel Pharmaceuticals (RIGL)

Fintel reports that State Street has filed a 13G form with the SEC disclosing ownership of 3.37MM shares of Rigel Pharmaceuticals, Inc. ().This represents 1.95% of the company. In their …

95%
OFF

State Street Cuts Stake In Rigel Pharmaceuticals (RIGL)

1 week from now

Fintel reports that State Street has filed a 13G form with the SEC disclosing ownership of 3.37MM shares of Rigel Pharmaceuticals, Inc. ().This represents 1.95% of the company. In their …

nasdaq.com

$21.08
OFF

HC Wainwright Has Bullish Estimate For RIGL Q4 Earnings

1 week from now

1 day ago · The stock's fifty day moving average price is $21.08 and its 200 day moving average price is $15.62. Rigel Pharmaceuticals has a 1-year low of $7.48 and a 1-year high of $29.82. …

marketbeat.com

$57
OFF

Rigel Pharmaceuticals Reports Preliminary Q4 Results; Issues

1 week from now

4 days ago · (RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. …

nasdaq.com

47%
OFF

Owning 47% Shares,institutional Owners Seem Interested In Rigel ...

1 week from now

Mar 6, 2024 · Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), [email protected] (Simply Wall St) Wed, Mar 6, 2024, …

yahoo.com

45%
OFF

With 45% Stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Seems …

1 week from now

Aug 29, 2024 · With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest [email protected] (Simply Wall St) Thu, …

yahoo.com

1%
OFF

Rigel Pharma Remains Bullish, Growth Fueled By FDA-Approved …

1 week from now

Oct 10, 2024 · In recent months, Rigel Pharmaceuticals (NASDAQ:RIGL) has surged by nearly 50.1% since July. RIGL’s strength lies in its successful execution, innovative portfolio, strategic …

seekingalpha.com

47%
OFF

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Is Definitely On The …

1 week from now

Sep 28, 2023 · Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is definitely on the radar of institutional investors who own 47% of the company [email protected] (Simply …

yahoo.com

$3.74
OFF

Fmr Cuts Stake In Rigel Pharmaceuticals (RIGL) - Nasdaq

1 week from now

As of February 8, 2023, the average one-year price target for Rigel Pharmaceuticals is $3.74. The forecasts range from a low of $0.91 to a high of $15.75. The forecasts range from a low of …

nasdaq.com

FAQs about State Street Cuts Stake in Rigel Pharmaceuticals (RIGL) Coupon?

Should you buy Rigel Pharmaceuticals (Rigl)?

Rigel Pharmaceuticals (RIGL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. A company's changing earnings picture is at the core of the Zacks rating. ...

Who owns Rigel Pharmaceuticals (Rigl)?

To get a sense of who is truly in control of Rigel Pharmaceuticals, Inc. ( NASDAQ:RIGL ), it is important to understand the ownership structure of the business. We can see that institutions own the lion's share in the company with 47% ownership. ...

When will Rigel Pharmaceuticals report its third quarter 2024 financial results?

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2024 financial results after market close on Thursday, November 7, 2024. ...

Why has Rigel Pharmaceuticals soared 50 percent?

Rigel Pharmaceuticals has surged 50.1% since my previous article, driven by successful execution, innovative portfolio, strategic partnerships, and pipeline progress. RIGL's FDA-approved drugs, Tavalisse, Rezlidhia, and Gavreto, are key revenue drivers. ...

Does Rigel Pharmaceuticals have a share registry?

We would expect most companies to have some institutions on the register, especially if they are growing. Rigel Pharmaceuticals already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. ...

Do hedge funds own 15% of Rigel Pharmaceuticals shares?

It looks like hedge funds own 15% of Rigel Pharmaceuticals shares. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. Armistice Capital LLC is currently the company's largest shareholder with 9.2% of shares outstanding. ...